Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Growth To $9.22 Billion Creates New Opportunities Across The Industry
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market CAGR Outlook And Future Development
The messenger ribonucleic acid (mrna) synthesis and manufacturing market size has experienced rapid growth in recent years. It is anticipated to expand from $5.14 billion in 2025 to $5.79 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.6%. The expansion observed historically can be ascribed to several factors, including the limited availability of mRNA synthesis platforms, the early stages of research in mRNA therapeutics, a reliance on small-scale laboratory production methods, nascent regulatory frameworks, and the high costs associated with purification and formulation services.
The messenger ribonucleic acid (mrna) synthesis and manufacturing market size is anticipated to experience significant growth over the next few years. It is projected to expand to $9.22 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. This expansion during the forecast period can be attributed to technological improvements in automated mRNA synthesis, the establishment of more commercial-scale mRNA manufacturing facilities, increasing investment in vaccine and therapeutic development, a rising demand for self-amplifying mRNA and new formulations, and an increase in preclinical and clinical research collaborations. Dominant trends during this period include a growing adoption of GMP-compliant mRNA synthesis, an escalating need for large-scale mRNA production, the expansion of mRNA therapeutics and vaccine pipelines, a stronger focus on purification, capping, and tailing services, and the increasing integration of mRNA-LNP formulations and stability testing.
Get A Free Sample Report With In-Depth Market Insights:
Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing prevalence of infectious diseases is anticipated to propel the growth of the messenger ribonucleic acid (mRNA) synthesis and manufacturing market going forward. Infectious diseases are conditions caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, including illnesses like malaria that can spread directly or indirectly. The rising incidence of infectious diseases is a consequence of rapid urbanization, which results in higher population density and close human contact, thus facilitating the spread of infections. mRNA synthesis and manufacturing contribute to combating infectious diseases by enabling the swift development and scalable production of targeted vaccines and therapeutics designed to stimulate a specific immune response. For instance, in October 2024, the World Health Organization, a Switzerland-based international public health organization, indicated that approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, an increase from about 7.5 million in 2022, thereby identifying tuberculosis as the leading infectious disease killer. Consequently, the growing prevalence of infectious diseases is a significant driver for the messenger ribonucleic acid (mRNA) synthesis and manufacturing market’s expansion.
Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Segmentation: How Does The Market Break Down By Category?
The messenger ribonucleic acid (mrna) synthesis and manufacturing market covered in this report is segmented –
1) By Service Type: Messenger Ribonucleic Acid (mRNA) Drug Synthesis, Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis
2) By Scale Of Operation: Preclinical, Clinical, Commercial
3) By Therapeutic Area: Infectious Diseases, Oncology, Other Therapeutic Areas
4) By Application: Vaccine Production, Therapeutic Development, Drug Discovery, Other Applications
Subsegments:
1) By Messenger Ribonucleic Acid (mRNA) Drug Synthesis: Custom Messenger Ribonucleic Acid (mRNA) Synthesis, GMP-Grade Messenger Ribonucleic Acid (mRNA) Synthesis, Large-Scale Messenger Ribonucleic Acid (mRNA) Synthesis, Modified Messenger Ribonucleic Acid (mRNA) Synthesis, Capping And Tailing Services, Purification Services
2) By Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis: Preclinical Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, Clinical-Grade Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, GMP-Compliant Vaccine Batch Production, Self-Amplifying Messenger Ribonucleic Acid (mRNA) Synthesis, Messenger Ribonucleic Acid (mRNA)-LNP Formulation Services For Vaccines, Stability Testing And QC Services
#Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Growth Trends: What’s Shaping The Future Outlook?
Leading firms within the messenger ribonucleic acid (mRNA) synthesis and manufacturing market are prioritizing the creation of novel solutions, such as co-transcriptional capping platforms, to expedite early-stage studies and alleviate compliance hurdles. A co-transcriptional capping platform represents an exclusive technique for attaching a safeguarding cap to messenger ribonucleic acid (mRNA) molecules during their creation, thereby improving mRNA resilience, translatability, and management of immune response. As an example, during May 2025, GenScript, a US-headquartered firm specializing in life sciences research instruments, introduced its good manufacturing practice (GMP)-like messenger ribonucleic acid (mRNA) manufacturing service. This service offers scalable, compliance-conscious manufacturing designed to yield highly pure, effective mRNA for preclinical studies supporting Investigational New Drug (IND) applications, encompassing toxicity, distribution within the body, and pharmacokinetics or pharmacodynamics (PK or PD) evaluations. Operating within environments adhering to cleanroom standards and International Organization for Standardization (ISO) 7 classification, it integrates patented co-transcriptional capping technology. Clients can receive tailored mRNA from this service in as few as seven weeks. The innovation effectively spans the critical developmental divide separating research-level production from comprehensive GMP manufacturing, allowing nascent biotechnology and pharmaceutical enterprises to undertake studies that meet regulatory requirements while bypassing the substantial expenses and time inefficiencies associated with conventional GMP processes.
Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Competitive Overview And Top Companies
Major companies operating in the messenger ribonucleic acid (mrna) synthesis and manufacturing market are Thermo Fisher Scientific Inc., Evonik Industries AG, Moderna Inc., BioNTech SE , AGC Biologics A/S, Eurofins Scientific SE, Lonza Group AG, Catalent Inc., WuXi Biologics (Cayman) Inc., Samsung Biologics Co Ltd., GenScript Biotech Corporation, Arcturus Therapeutics Holdings Inc., New England Biolabs Inc., CureVac N.V., Abzena plc, Creative Biolabs Inc., Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC
View The Full Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Report:
Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the messenger ribonucleic acid (mRNA) synthesis and manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) synthesis and manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
